[The new synthetic gestagen danazol in the treatment of endometriosis, fibrosystic disease of the breast and prolonged primary infertility (author's transl)].
article
OA: closed
CC0
⤵ 6 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
Danazol, a synthetic gestagen, was evaluated for its efficacy in treating endometriosis, fibrocystic breast disease, and prolonged primary infertility.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (6)
- Placebo-controlled comparison of hormonal and biochemical effects of danazol and high-dose medroxyprogesterone acetate 1990
- The effect of danazol on gonadotropin secretion during the follicular phase of the menstrual cycle 1983
- Danazol and gestagen displacement of testosterone and influence on sex-hormone-binding globulin capacity 1982
- Changes of Prolactin Secretion Following Long-Term Danazol Application 1981
- The effect of Danazol on the pituitary function, thyroid function, and mastodynia 1980
- Danazol in the Treatment of Endometriosis 1980
Source provenance
- europepmc
- last seen: 2026-06-17T06:13:18.893374+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-14T05:58:53.789372+00:00
License: CC0
· commercial use OK